Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Researchers at Indiana University School of Medicine have developed a blood test for stress. This test assesses a person's risk of stress,...
Read Full NewsCould timing prostate cancer radiotherapy according to patients’ circadian rhythm genes reduce the risk for late side effects?
Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.
Researchers retrospectively analyzed outcomes for 50 patients with biopsy-proven monoclonal gammopathy of renal significance for a median follow-up of 6.15 years.
In a small single-center study, 1-year survival is 100% among carefully selected patients who undergo bilateral lung transplantation for stage IV disease confined to the lungs.
1.
Modified personalized cancer vaccine generates powerful immune response
2.
Is There a Role for Stimulants in Beating Cancer Fatigue?
3.
HER2 ADC Shows Promise in Recurrent Endometrial Cancer
4.
New research demonstrates a method for screening people at high risk for pancreatic cancer.
5.
According to JAMA, even four minutes a day of exercise can lower the risk of cancer.
1.
Intravenous Calcium for Reducing Blood Loss During Cesarean Delivery: A Review of Current Evidence
2.
Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment
3.
Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment
4.
Ultimate Guide to Oncology Services in the USA
5.
Bone Marrow Regeneration in Hematologic Recovery
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Current Scenario of Cancer- Q&A Session to Close the Gap
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge